A system biology approach based on metabolic biomarkers and protein–protein interactions for identifying pathways underlying schizophrenia and bipolar disorder
Abstract Mental disorders (MDs), including schizophrenia (SCZ) and bipolar disorder (BD), have attracted special attention from scientists due to their high prevalence and significantly debilitating clinical features. The diagnosis of MDs is still essentially based on clinical interviews, and intens...
Guardado en:
Autores principales: | Md. Altaf-Ul-Amin, Kazuhisa Hirose, João V. Nani, Lucas C. Porta, Ljubica Tasic, Shaikh Farhad Hossain, Ming Huang, Naoaki Ono, Mirian A. F. Hayashi, Shigehiko Kanaya |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f6fc63593aca457889b7bc465218da0b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Shared and differential cortical functional abnormalities associated with inhibitory control in patients with schizophrenia and bipolar disorder
por: Noa Tsujii, et al.
Publicado: (2018) -
Update on schizophrenia and bipolar disorder: focus on cariprazine
por: Roberts RJ, et al.
Publicado: (2016) -
Contextual social cognition impairments in schizophrenia and bipolar disorder.
por: Sandra Baez, et al.
Publicado: (2013) -
Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia.
por: Daniela Galimberti, et al.
Publicado: (2012) -
Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders
por: El-Khalili N
Publicado: (2012)